2018-08902. Submission for OMB Review; 30-Day Comment Request  

  • Start Preamble

    CTEP Branch and Support Contracts Forms and Surveys (National Cancer Institute)

    AGENCY:

    National Institutes of Health, HHS.

    ACTION:

    Notice.

    SUMMARY:

    In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.

    DATES:

    Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.

    ADDRESSES:

    Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, Attention: Desk Officer for NIH.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Michael Montello, Pharm.D., Shanda Finnigan, MPH, RN, CCRC or Jacquelyn Goldberg, JD, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, 9609 Medical Center Drive, Rockville, MD 20850 or call non-toll-free number (240-276-6080) or email your request, including your address to: ctsucontact@westat.com.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    This proposed information collection was previously published in the Federal Register on February 21, 2018, page 7483 (83 FR 7483) and allowed 60 days for public comment. No public comments were received. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.

    Proposed Collection: CTEP Branch and Support Contracts Forms and Surveys, 0925-0753 Expiration Date 06/30/2020, REVISION, National Cancer Institute (NCI), National Institutes of Health (NIH).

    Need and Use of Information Collection: The National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) and the Division of Cancer Prevention (DCP) fund an extensive national program of cancer research, sponsoring clinical trials in cancer prevention, symptom management and treatment for qualified clinical investigators. As part of this effort, CTEP implements programs to register clinical site investigators and clinical site staff, and to oversee the conduct of research at the clinical sites. CTEP and DCP also oversee two support programs, the NCI Central Institutional Review Board (CIRB) and the Cancer Trial Support Unit (CTSU). The combined systems and processes for Start Printed Page 18577initiating and managing clinical trials is termed the Clinical Oncology Research Enterprise (CORE) and represents an integrated set of information systems and processes which support investigator registration, trial oversight, patient enrollment, and clinical data collection. The information collected is required to ensure compliance with applicable federal regulations governing the conduct of human subjects research (45 CFR 46 and 21 CRF 50), and when CTEP acts as the Investigational New Drug (IND) holder, FDA regulations pertaining to the sponsor of clinical trials and the selection of qualified investigators under 21 CRF 312.53). Information is also collected through surveys to assess satisfaction, provide feedback to guide improvements with processes and technology, and assess health professional's interests in clinical trials.

    To increase efficiencies, reduce administrative burden and cost, CTEP has requested consolidation of their current OMB submission. Consolidation is justified because although the various branches and contracts are responsible for distinct services, the processes that support the NCI and participating clinical sites efforts are intertwined. This revision of the previous submission includes changes to the NCI CIRB and CTSU form collections and integrates the Clinical Trials Monitoring Branch (CTMB) and Pharmaceutical Management Branch (PMB) form collections related to site audit and clinical investigator and key clinical site staff registration.

    OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 112,798.

    Estimated Annualized Burden Hours

    Form nameType of respondentNumber of respondentsNumber of responses per respondentAverage burden per response (in hours)Total annual burden hours
    CTSU IRB/Regulatory Approval Transmittal Form (Attachment A01)Health Care Practitioner2,444122/60978
    CTSU IRB Certification Form (Attachment A02)Health Care Practitioner2,4441210/604,888
    Withdrawal from Protocol Participation Form (Attachment A03)Health Care Practitioner279110/6047
    Site Addition Form (Attachment A04)Health Care Practitioner801210/60160
    CTSU Roster Update Form (Attachment A05)Health Care Practitioner60015/6050
    CTSU Request for Clinical Brochure (Attachment A06)Health Care Practitioner360110/6060
    CTSU Supply Request Form (Attachment A07)Health Care Practitioner901210/60180
    Site Initiated Data Update Form (Attachment A08)Health Care Practitioner21210/604
    Data Clarification Form (Attachment A09)Health Care Practitioner1502410/60600
    RTOG 0834 CTSU Data Transmittal Form (Attachment A10)Health Care Practitioner127610/60152
    CTSU Generic Data Transmittal Form (Attachment A12)Health Care Practitioner51210/6010
    CTSU Patient Enrollment Transmittal Form (Attachment A15)Health Care Practitioner121210/6024
    CTSU Transfer Form (Attachment A16)Health Care Practitioner360210/60120
    CTSU System Access Request Form (Attachment A17)Health Care Practitioner180120/6060
    CTSU OPEN Rave Request Form (Attachment A18)Health Care Practitioner302110/60105
    CTSU LPO Form Creation (Attachment A19)Health Care Practitioner52120/6020
    CTSU Site Form Creation and PDF (Attachment A20)Health Care Practitioner4001030/602,000
    CTSU PDF Signature Form (Attachment A21)Health Care Practitioner4001010/60667
    NCI CIRB AA & DOR between the NCI CIRB and Signatory Institution (Attachment B01)Participants50115/6013
    NCI CIRB Signatory Enrollment Form (Attachment B02)Participants50115/6013
    CIRB Board Member Application (Attachment B03)Board Member100130/6050
    CIRB Member COI Screening Worksheet (Attachment B08)Board Members100115/6025
    CIRB COI Screening for CIRB meetings (Attachment B09)Board Members72115/6018
    CIRB IR Application (Attachment B10)Health Care Practitioner80160/6080
    CIRB IR Application for Exempt Studies (Attachment B11)Health Care Practitioner4130/602
    CIRB Amendment Review Application (Attachment B12)Health Care Practitioner400115/60100
    CIRB Ancillary Studies Application (Attachment B13)Health Care Practitioner1160/601
    CIRB Continuing Review Application (Attachment B14)Health Care Practitioner400115/60100
    Adult IR of Cooperative Group Protocol (Attachment B15)Board Members651180/60195
    Start Printed Page 18578
    Pediatric IR of Cooperative Group Protocol (Attachment B16)Board Members151180/6045
    NCI Adult/Pediatric Continuing Review of Cooperative Group Protocol (Attachment B17)Board Members275160/60275
    Adult Amendment of Cooperative Group Protocol (Attachment B19)Board Members401120/6080
    Pediatric Amendment of Cooperative Group Protocol (Attachment B20)Board Members251120/6050
    Pharmacist's Review of a Cooperative Group Study (Attachment B21)Board Members501120/60100
    Adult Expedited Amendment Review (Attachment B23)Board Members348130/60174
    Pediatric Expedited Amendment Review (Attachment B24)Board Members140130/6070
    Adult Expedited Continuing Review (Attachment B25)Board Members140130/6070
    Pediatric Expedited Continuing Review (Attachment B26)Board Members36130/6018
    Adult Cooperative Group Response to CIRB Review (Attachment B27)Health Care Practitioner30160/6030
    Pediatric Cooperative Group Response to CIRB Review (Attachment B28)Health Care Practitioner5160/605
    Adult Expedited Study Chair Response to Required Modifications (Attachment B29)Board Members40130/6020
    Reviewer Worksheet- Determination of UP or SCN (Attachment B31)Board Members400110/6067
    Reviewer Worksheet -CIRB Statistical Reviewer Form (Attachment B32)Board Members100115/6025
    CIRB Application for Translated Documents (Attachment B33)Health Care Practitioner100130/6050
    Reviewer Worksheet of Translated Documents (Attachment B34)Board Members100115/6025
    Reviewer Worksheet of Recruitment Material (Attachment B35)Board Members20115/605
    Reviewer Worksheet Expedited Study Closure Review (Attachment B36)Board Members20115/605
    Reviewer Worksheet of Expedited IR (Attachment B38)Board Members5130/603
    Annual Signatory Institution Worksheet About Local Context (Attachment B40)Health Care Practitioner400140/60267
    Annual Principal Investigator Worksheet About Local Context (Attachment B41)Health Care Practitioner1,800120/60600
    Study-Specific Worksheet About Local Context (Attachment B42)Health Care Practitioner4,800120/601,600
    Study Closure or Transfer of Study Review Responsibility (Attachment B43)Health Care Practitioner1,680120/60560
    Unanticipated Problem or Serious or Continuing Noncompliance Reporting Form (Attachment (B44)Health Care Practitioner360120/60120
    Change of Signatory Institution PI Form (Attachment B45)Health Care Practitioner120120/6040
    Request Waiver of Assent Form (Attachment B46)60120/6020
    CTSU OPEN Survey (Attachment C03)Health Care Practitioner60115/6015
    CIRB Customer Satisfaction Survey (Attachment C04)Participants600115/60150
    Follow-up Survey (Communication Audit) (Attachment C05)Participants/Board Members300115/6075
    CIRB Board Member Annual Assessment Survey (Attachment C07)Board Members60115/6015
    PIO Customer Satisfaction Survey (Attachment C08)Health Care Practitioner6015/605
    Concept Clinical Trial Survey (Attachment C09)Health Care Practitioner50015/6042
    Prospective Clinical Trial Survey (Attachment C10)Health Care Practitioner1,00011/6017
    Low Accrual Clinical Trial Survey (Attachment C11)Health Care Practitioner1,00011/6017
    Start Printed Page 18579
    Audit Scheduling Form (Attachment D01)Group/CTMS Users152521/60266
    Preliminary Audit Findings Form (Attachment D02)Auditor152510/60127
    Audit Maintenance Form (Attachment D03)Group/CTMS Users15259/60114
    Final Audit Finding Report Form (Attachment D04)Group/CTMS Users75111,098/6015,098
    Follow-up Form (Attachment D05)Group/CTMS Users75727/60236
    Roster Maintenance Form (Attachment D06)CTMS Users5118/602
    Final Report and CAPA Request Form (Attachment D07)CTMS Users1291,800/603240
    NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01)Physician23,000115/605,750
    NCI/DCTD/CTE Biosketch (Attachment E02)Physician; Health Care Practitioner33,0001120/6066,000
    NCI/DCTD/CTEP Financial Disclosure Form (Attachment E03)Physician; Health Care Practitioner33,00015/602,750
    NCI/DCTD/CTEP Agent Shipment Form (ASF) (Attachment E04)Physician23,000110/603,833
    Totals136,487207,989112,838
    Start Signature

    Dated: April 12, 2018.

    Karla Bailey,

    Project Clearance Liaison, National Cancer Institute, National Institutes of Health.

    End Signature End Supplemental Information

    [FR Doc. 2018-08902 Filed 4-26-18; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
04/27/2018
Department:
National Institutes of Health
Entry Type:
Notice
Action:
Notice.
Document Number:
2018-08902
Dates:
Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
Pages:
18576-18579 (4 pages)
PDF File:
2018-08902.pdf